Matsen Life Sciences SRL
Matsen Life Sciences reported total assets of 73,064 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Matsen Life Sciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +24 % Total assets -24 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Matsen Life Sciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
Matsen Life Sciences's financial analysis
- Solvency96.3%sector median: 75.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Matsen Life Sciences
Matsen Life Sciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0782.905.509
- VAT number
- BE0782905509
- Peppol
- Registered · 0208:0782905509 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Mar 2022
- Registered office
- 1840 Londerzeel
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Matsen Life Sciences (SRL) has been based in Londerzeel since 2022, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 49,004 € and equity of 70,372 €; its revenue is not published. Its solvency stands at 96.3%, above the median of its sector (75.0%).
Companies similar to Matsen Life Sciences
Companies in the same business, of comparable size and area, outside its group.
- Estrella Clinical Research Manufacture of basic pharmaceutical products Herentals · balance sheet 41,482 €
- Epsilon-Biotech Research and experimental development on natural sciences and engineering Zonhoven · balance sheet 244,785 €
- Dokter Adriaan Daniels General medical practice activities Grimbergen · balance sheet 207,908 €
- Dr. Britt Royers General medical practice activities Antwerp · balance sheet 247,577 €
- Biocli Consult Research and experimental development on natural sciences and engineering Jurbise · balance sheet 302,775 €
- Analytikk Diagnostic imaging services and medical laboratory activities Beveren-Kruibeke-Zwijndrecht · balance sheet 524,362 €
- Raf Schepers Klinische Biologie Diagnostic imaging services and medical laboratory activities Meise · balance sheet 327,535 €
- Spectralys Biotech Research and experimental development on natural sciences and engineering Charleroi · balance sheet 444,695 €
Frequently asked questions about Matsen Life Sciences
What is the revenue of Matsen Life Sciences?
Matsen Life Sciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Matsen Life Sciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0782905509 for Matsen Life Sciences, if the company is VAT-registered. Its company number (CBE) is 0782.905.509.
Where is the registered office of Matsen Life Sciences?
According to the CBE register, the registered office of Matsen Life Sciences is in 1840 Londerzeel.
What is the equity of Matsen Life Sciences?
At the close of the 2025 financial year, the equity of Matsen Life Sciences amounts to 70,372 €, a solvency of 96.3% of total assets.
Who manages Matsen Life Sciences?
The register lists 1 active mandates at Matsen Life Sciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Matsen Life Sciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →